More on MXCT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.7 Score)

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

MaxCyte, Inc. (NQ:MXCT)
Delayed: 1.24 -0.05 (3.88%)
Prev. Close $1.29  
Open$1.26 
52 Wk High$ 
52 Wk Low$ 
Day High$1.28 
Day Low$1.22 
P/E N/A  
EPS$ 
Volume678,902 

Friends, Peers and Foes (?): MXCN (more...)

Aug 24, 2026 06:17 AM BTIG Reiterates Neutral Rating on MaxCyte Inc. (MXCT)
Aug 19, 2026 08:06 AM MaxCyte adds two off-target assays for base editor genome therapies
Aug 19, 2026 08:05 AM MaxCyte launches CHANGE-seq-BE™ and ONE-seq-BE™ to strengthen off-target assessment for genome editing therapies
Aug 13, 2026 04:35 PM Form 10-Q MAXCYTE, INC. For: Jun 30
Aug 12, 2026 05:09 PM MaxCyte, Inc. (MXCT) Reports In-Line Q2 EPS
Aug 12, 2026 04:15 PM Form 8-K MAXCYTE, INC. For: Aug 12
Aug 12, 2026 04:05 PM MaxCyte Reports Second Quarter 2026 Financial Results
Aug 4, 2026 08:43 AM Form SCHEDULE 13D MAXCYTE, INC. Filed by: RIVER GLOBAL INVESTORS LLP
Jul 29, 2026 03:20 PM Form SCHEDULE 13G/A MAXCYTE, INC. Filed by: BlackRock, Inc.
Jul 21, 2026 08:05 AM MaxCyte signs technology license deal with Genentech for cell therapy
View All Articles

Entities mentioned with MXCT

View All Entities